jCyte was founded by Henry Klassen, Jing Yang.

How much funding has jCyte raised?

jCyte has disclosed $3.9M raised across 1 round.

Where is jCyte headquartered?

jCyte is headquartered in Newport Beach, US.

jCyte

Newport Beach, US · Delaware corporation

jCyte is a clinical-stage biotechnology company developing jCell, an investigational cell-based therapy for retinitis pigmentosa and other inherited retinal and blinding diseases. It is advancing multiple drug development programs targeting degenerative retinal disorders and optic nerve conditions to preserve and restore vision.

Biotech Healthtech

Founders & leadership

Henry KlassenCo-founder

Jing YangCo-founder

Paul BresgeExecutive

Terry O'NealExecutive

Reported raises · per SEC filings

Form D private placements

$3.9M disclosed across 1 round · 2019

▶$3.9MraisedApr 2019 · 53 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Henry KlassenDirector
Paul BresgeExecutive Officer
Terry O'NealExecutive Officer, Director
Jing YangDirector

Offering amount: $6M
Amount sold: $3.9M
First sale: Mar 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Incyte Corporation17 shared keywordsIncyte is a global biopharmaceutical company that develops medicines across hematology, oncology, and inflammation and autoimmunity, with clinical programs spanning areas such as dermatology. It focuses on research and development of treatments for patients.

Kite Pharma9 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.

シンクサイト6 shared keywordsThinkCyte develops diagnostic devices and cellular analysis platforms using imaging flow cytometry and microfluidics technology. The company serves research institutions, clinical laboratories, and biopharmaceutical companies in the life sciences and diagnostic tools sector.

Companies competing with jCyte for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does jCyte do?: jCyte is a clinical-stage biotechnology company developing jCell, an investigational cell-based therapy for retinitis pigmentosa and other inherited retinal and blinding diseases. It is advancing multiple drug development programs targeting degenerative retinal disorders and optic nerve conditions to preserve and restore vision.
Who founded jCyte?: jCyte was founded by Henry Klassen, Jing Yang.
How much funding has jCyte raised?: jCyte has disclosed $3.9M raised across 1 round.
Where is jCyte headquartered?: jCyte is headquartered in Newport Beach, US.